107367-98-6

Basic information

• Product Name: 2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ACETIC ACID
• Synonyms: 2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ACETIC ACID;(5-METHYL-2-PHENYLOXAZOL-4-YL)ACETIC ACID;BUTTPARK 37\06-80;(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ACETIC ACID;2-(5-Methyl-2-phenyl-oxazol-4-yl)-acetic acid
• CAS NO: 107367-98-6
• Molecular Formula: C₁₂H₁₁NO₃
• Molecular Weight: 217.22
• Product Categories: Carboxylic Acids;Oxazoles, Isoxazoles & Benzoxazoles;Carboxylic Acids;Oxazoles, Isoxazoles & Benzoxazoles
• Mol File: 107367-98-6.mol
• Article Data: 11

Chemical Properties

• Melting Point: 131 °C
• Boiling Point: 411.7 °C at 760 mmHg
• Flash Point: 202.8 °C
• Appearance: /
• Density: 1.245 g/cm³
• Vapor Pressure: 1.63E-07mmHg at 25°C
• Refractive Index: 1.569
• Storage Temp.: 2-8°C
• PKA: 3.80±0.10(Predicted)
• CAS DataBase Reference: 2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ACETIC ACID(107367-98-6)
• EPA Substance Registry System: 2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ACETIC ACID(107367-98-6)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 107367-98-6(Hazardous Substances Data)

Usage

Description

2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid is a chemical compound characterized by the presence of an oxazole ring—a five-membered heterocyclic ring with one oxygen and one nitrogen atom, along with three carbon atoms. This specific compound features a 5-methyl-2-phenyl substitution on the oxazole ring, and an acetic acid ester is attached to the 2nd carbon atom. Although its physical properties and potential applications are not extensively studied, the general presence of oxazoles in various bioactive compounds suggests that this compound may hold significant therapeutic potential, warranting further research.

Uses

Given the limited information on the specific applications of 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid, the following uses are inferred based on the general utility of oxazole-containing compounds in the pharmaceutical and chemical industries:
Used in Pharmaceutical Industry:
2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid is used as a building block or intermediate in the synthesis of pharmaceuticals for its potential to contribute to the development of new drugs with diverse therapeutic benefits. The presence of the oxazole ring may enhance the compound's bioactivity, making it a valuable component in medicinal chemistry.
Used in Chemical Research:
In the field of chemical research, 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid serves as a subject for investigation to explore its physical and chemical properties, as well as its reactivity with other compounds. Understanding these properties can lead to the discovery of new reactions or applications in organic synthesis.
Used in Bioactive Compounds Development:
2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid is utilized as a key structural element in the design and synthesis of bioactive compounds, potentially leading to the creation of novel agents with applications in various therapeutic areas, given the known importance of oxazoles in natural and synthetic bioactive molecules.

InChI:InChI=1/C12H11NO3/c1-8-10(7-11(14)15)13-12(16-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3,(H,14,15)

Upstream product

• 100-52-7 benzaldehyde 
• 258346-54-2 3-(5-methyl-2-phenyl-4-oxazolyl)propionitrile 
• 54819-26-0 methyl 3-(benzoylamino)-4-oxovalerate 
• 39741-26-9 N-benzoyl-L-aspartic acid β-methyl ester 
• 103788-61-0 (5-methyl-2-phenyl-4-oxazolyl)methyl chloride 
• 27492-46-2 4,5-dimethyl-2-phenyl-oxazole 3-oxide 
• 524959-64-6 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetonitrile 
• 103788-64-3 methyl 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetate 
• 186895-16-9 5-Methyl-4-hydroxyethyl-2-phenyl-oxazole 
• 100373-13-5 methyl 3-benzamido-4-oxovalerate 
• 98-88-4 benzoyl chloride 

Downstream Products

• 1394014-09-5 C₂₅H₂₈N₂O₅ 
• 1394014-10-8 C₂₅H₂₈N₂O₅ 
• 1394014-11-9 C₂₆H₂₈N₂O₅ 
• 1394014-12-0 C₂₆H₂₈N₂O₅ 
• 888707-94-6 C₂₄H₂₆N₂O₅ 
• 888707-96-8 C₂₄H₂₆N₂O₅ 
• 888708-07-4 C₂₅H₂₈N₂O₅ 
• 888708-09-6 C₂₅H₂₈N₂O₅ 
• 1584693-24-2 ethyl 4-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-3-oxobutanoate 
• 1415228-22-6 C₂₄H₂₆N₂O₅ 
• 1415228-26-0 C₂₂H₂₂N₂O₅ 
• 1394014-05-1 C₂₅H₂₈N₂O₅ 
• 1394014-06-2 C₂₅H₂₈N₂O₅ 
• 888707-86-6 C₂₆H₃₀N₂O₅ 

Relevant articles and documents

Design and synthesis of Oxime ethers of β-oxo-γ-phenylbutanoic acids as PPAR a and -γ dual agonists

Oxime ethers of p-oxo-y-phenylbutanoic acids were prepared to develop more effective PPAR a and y dual agonists. Among them, compound 11k exhibited potent in vitro activities with EC50 of 2.5 nM and 3.3 nM in PPAR a and y, respectively. It showed better g

Design and synthesis of oxime ethers of α-acyl-β-phenylpropanoic acids as PPAR dual agonists

Oxime ethers of α-acyl-β-phenylpropanoic acids were prepared to apply as PPARα and γ dual agonists. Among them, compound 11l proved to exhibit potent in vitro activities with EC50 of 19 and 13 nM in PPARα and γ, respectively. It showed better g

Antidiabetic agents

The present invention provides compounds of Formula (I): wherein A, X, Q, Y, B, D, Z, and E have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful as antidiabetic agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.